Versatile virus-like particle carrier for epitope based vaccines
about
sameAs
Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Towards a universal influenza vaccine: volunteer virus challenge studies in quarantine to speed the development and subsequent licensingVLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirusThe S. aureus 4-oxalocrotonate tautomerase SAR1376 enhances immune responses when fused to several antigens.Influenza A viruses: why focusing on M2e-based universal vaccines.Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza.Development of a Novel Virus-Like Particle Vaccine Platform That Mimics the Immature Form of Alphavirus.A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice.Development of a mimotope vaccine targeting the Staphylococcus aureus quorum sensing pathway.Titrating T-cell epitopes within self-assembled vaccines optimizes CD4+ helper T cell and antibody outputsPlug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization.Bacterial superglue enables easy development of efficient virus-like particle based vaccines.A novel M2e based flu vaccine formulation for dogs.Antigenic analysis of monoclonal antibodies against different epitopes of σB protein of avian reovirus.A novel tuberculosis DNA vaccine in an HIV-1 p24 protein backbone confers protection against Mycobacterium tuberculosis and simultaneously elicits robust humoral and cellular responses to HIV-1Early Transcriptome Signatures from Immunized Mouse Dendritic Cells Predict Late Vaccine-Induced T-Cell Responses.A Conserved Epitope Mapped with a Monoclonal Antibody against the VP3 Protein of Goose Parvovirus by Using Peptide Screening and Phage Display Approaches.Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery.Display of single-chain variable fragments on bacteriophage MS2 virus-like particles.Engineering virus-like particles as vaccine platformsViral nanoparticles and virus-like particles: platforms for contemporary vaccine design.Towards artificial metallonucleases for gene therapy: recent advances and new perspectives.Hepatitis B core-based virus-like particles to present heterologous epitopes.Advances and challenges in the development and production of effective plant-based influenza vaccines.The application of virus-like particles as vaccines and biological vehicles.Different applications of virus-like particles in biology and medicine: Vaccination and delivery systems.Virus-based nanoparticles as platform technologies for modern vaccines.Immunocontraception: Filamentous Bacteriophage as a Platform for Vaccine Development.Mapping a Type-specific Epitope by Monoclonal Antibody against VP3 Protein of Duck Hepatitis A Type 1 Virus.Evaluation of lumazine synthase from Bacillus anthracis as a presentation platform for polyvalent antigen display.Adjuvant effect of B domain of staphyloccocal protein A displayed on the surface of hepatitis B virus capsid.Target highlights from the first post-PSI CASP experiment (CASP12, May-August 2016).Mosaic RNA phage VLPs carrying domain III of the West Nile virus E protein.Yeast-expressed bacteriophage-like particles for the packaging of nanomaterials.The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation.Universal influenza vaccine: the holy grail?Effects of pre-existing anti-carrier immunity and antigenic element multiplicity on efficacy of a modular virus-like particle vaccine.Universal vaccine against influenza virus: linking TLR signaling to anti-viral protection.Potato virus Y-like particles as a new carrier for the presentation of foreign protein stretches.Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses.
P2860
Q26830028-C96BBF89-A33C-4EAE-94BF-AC4DD6E5A085Q27003874-26EBCC55-165F-4BF7-921D-67CC13E20CE1Q28280059-272E5373-0D65-40F3-BC75-A1153CFED59EQ29994694-51E65E3C-07D2-4C0F-B6F7-E4EC15BC4983Q30396318-79CDA742-17F4-4F4E-BA16-1BF449C1E399Q30410241-6E41E8A8-06EE-48AE-A66B-C945DBF6564CQ33876183-4836D990-001F-466B-B774-C0EBDCC5A874Q34039347-6F165CEA-A490-4B1C-BBA1-E4EEB7909781Q34472793-66BE0918-E51C-473D-938F-3EF3400F10E3Q34490296-C256F4F6-833A-482E-B6EE-0B3599C605B9Q34509612-816F9395-8CBA-4A20-8250-14578F8C3FE2Q34523734-2876D4E6-F4F1-4FB7-B4E3-1FF13BB2E64CQ35009732-231435C0-8EC6-4EA1-AE59-28C9799D4E5BQ35060573-C8998C56-B3E9-4C27-A8D6-0B47B9B1576BQ35940744-775C4428-14A8-4B1E-94F2-2603A7F23F04Q35964579-872F487C-5F83-4D68-81D0-29FF7633A8CAQ36020868-D65CCB18-CD8B-4D43-B6A4-57BE333EBD61Q36155247-B14C92F2-6F14-4026-87B4-FDCBE9C0A8FCQ36279158-30A3D0F2-9855-47B1-93C0-9BDB99B167F9Q37172342-7D3ABFE2-9363-4CB1-A63F-0700A14ADE96Q37792984-3C93AAE3-5D35-438F-A50A-D9DA5D3B8A6BQ37948867-C9104E2F-C446-43A9-98C8-A84CFDEFA24EQ38081969-41651E65-DD12-4A1B-9CCA-1E39E5150941Q38285425-CBE6E20E-B055-4199-A50D-6ED77D0BAE01Q38603912-9BE56E37-13B2-4B46-9902-D66610C9D305Q38618258-CF43D8C2-2B00-4751-87D9-3FE3F0E2E2F7Q38702017-B3E3A1E6-6FAD-4ED8-B846-CF8317860BFCQ40044131-93573784-5257-4433-BE61-E703865BBC37Q40052216-418BA689-AC47-4786-A182-09F22EC2C87FQ40122953-73A73A95-4C45-433D-AF4F-4D59E1071E6EQ41534162-095C6134-80E1-40EC-A354-3C8511A2E098Q41928117-42816116-C386-4502-A722-BCD43DCB9984Q42235222-5C02DA24-0F23-4F3E-81B5-176A5F52E31DQ42283846-55BBA1CC-888F-4EFB-BAE7-1E0F3C7AB1F5Q42926219-27189CC8-9A86-47D1-B7C1-B7347EF53867Q43692141-2DEDF4B1-0CB5-4588-B72A-F18DDEAECC8AQ45157613-1E66212F-85B0-401B-93DB-D6DFC8092C5BQ45358078-4CC462E8-7FAE-4B7F-AF1E-8020D2A6453DQ45361083-42BBB5B2-5103-47D3-A24C-F3DDB7E65AFDQ47555220-896272C4-9836-44F5-B07F-9AC6DB37794E
P2860
Versatile virus-like particle carrier for epitope based vaccines
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Versatile virus-like particle carrier for epitope based vaccines
@ast
Versatile virus-like particle carrier for epitope based vaccines
@en
Versatile virus-like particle carrier for epitope based vaccines
@nl
type
label
Versatile virus-like particle carrier for epitope based vaccines
@ast
Versatile virus-like particle carrier for epitope based vaccines
@en
Versatile virus-like particle carrier for epitope based vaccines
@nl
prefLabel
Versatile virus-like particle carrier for epitope based vaccines
@ast
Versatile virus-like particle carrier for epitope based vaccines
@en
Versatile virus-like particle carrier for epitope based vaccines
@nl
P2093
P2860
P3181
P1433
P1476
Versatile virus-like particle carrier for epitope based vaccines
@en
P2093
Alain C Tissot
Edwin Meijerink
Gary T Jennings
Indulis Cielens
Martin F Bachmann
Nicole Schmitz
Paul Pumpens
Philippe Saudan
Regina Renhofa
P2860
P3181
P356
10.1371/JOURNAL.PONE.0009809
P407
P577
2010-03-23T00:00:00Z